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ABSTRACT 
We report a rare case of gastric fistulization in a patient with main-duct (MD) intraductal 
papillary mucinous neoplasm (IPMN). Fistulization to adjacent organs is a rare complication 
of this disease, mainly affecting the duodenum; the fact that the stomach was the only organ 
involved makes this case even more peculiar. The diagnosis of the fistula was made after 
examination with Endoscopic Ultrasound (EUS), since a previous computed tomography 










IPMNs belong to the category of cystic pancreatic tumors; their incidence is reported to vary 
from 0.31 to 4.35/100000.1 IPMNs can be classified into 3 groups, based on imaging 
features: MD-IPMN, characterized by diffuse or segmental dilation of the main pancreatic 
duct, branch duct (BD)-IPMN, characterized by pancreatic cysts in communication with a 
normal main pancreatic duct (MPD) and mixed type IPMN, when characteristics of both 
types are present. 2,3 Their main histological feature is the proliferation of mucin producing 
epithelial cells, with excessive production of mucus leading to dilation of the ducts. IPMNs 
can also be classified in benign, “borderline” and malignant according to the grade of the 
dysplasia of the proliferating cells.4 
IPMNs can show malignant transformation as a complication and, among all the other ones 
that may occur (i.e. hemorrhage, acute pancreatitis, perforation), fistulization to adjacent 
organs is the rarest.5 The duodenum seems to be the most common site of fistulization, 
followed by the stomach, the common bile duct and the colon. 




In 2015, a 72-year-old patient, with benign prostatic hyperplasia and a recent onset of 
diabetes mellitus, presented with abdominal mesogastric pain started some weeks before 
along with a 5 kg loss during the last months. Blood analysis showed inflammation with 
WBC 10470/mm3 and C reactive protein (CRP) 82 mg/dL. Abdominal US showed an 
inhomogeneous mass in the mesogastric-epigastric area, with some anechoic areas inside it. 
Subsequent CT scans demonstrated an inhomogeneous enlargement of the pancreatic head 
and neck, dilation of the MPD and cystic dilation of many collateral ducts. 
The patient was then referred to our Endoscopy Unit to undergo EUS. Endoscopically a 3 cm 
sub-epithelial yellowish mass was seen in the gastric antrum (Fig. 1) and, in the duodenum, a 
patulous ampulla of Vater with extruding mucus (the so-called fish-mouth sign) was noted 
(Fig. 2). EUS demonstrated a diffuse dilation of the MPD up to 17 mm, mucus filling the 
duct and cystic spaces containing contrast-enhanced papillae (SonoVue® 5 ml iv) (Fig. 3). 
Moreover, the nature of the gastric mass was discovered: fistulization of a side branch of the 
MPD into the gastric wall was revealed by EUS (Fig. 4). 
A diagnosis of MD-IPMN was made and the patient was sent to a surgical consultation but 




We report a rare case of MD-IPMN with a fistula involving the stomach in a 72-year old 
male presenting with abdominal pain. IPMNs are a rare entity among pancreatic tumors, and 
fistulization is one of their rarest complications. Incidence of fistulas in IPMNs varies in 
percentage according to different studies. We performed an analysis of the recent literature 
and, to our knowledge, the largest series of patients were described by Ravaud et al 6 in 2015 
(423 patients) and Kobayashi et al 7 in 2008 (274 patients): the percentage of fistulization 
ranged from 1.9% in the French study to 6.6% in the Japanese one. This difference can be 
explained by the diagnostic methods that were used in the two groups: MRI and/or CT in the 
former, EUS and/or endoscopic retrograde cholangiopancreatography (ERCP) in the latter. 
Furthermore in the French study, although 75% of the patients had more than one organ 
involved, the duodenum was affected in every single patient 6. 
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Conclusions 
The rarity of this case is explained by the fact that, in order of frequency, fistulas occur 
primarily to the duodenum and then to other organs, whereas in this case the stomach was 
the only organ involved.  
It should be kept in mind that fistulization does not strictly adhere to the criteria of 
malignancy since the mechanism involved includes either high mechanical pressure in the 
pancreatic ducts filled with mucin or inflammatory stimulation with direct invasion 8-10: it is 
possible to hypothesize that both mechanisms were here involved. 
It should be noted that, in our case, the fistula was eventually discovered by EUS 
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TITLES OF FIGURES 
Figure 1. a yellowish sub-epithelial mass was noted in the gastric antrum 
 
Figure 2. thick mucus extruded from a patulous ampulla of Vater 
 
Figure 3. contrast enhanced papillary projections after infusion of SonoVue® 5 ml i.v. 
 
Figure 4. a dilated pancreatic duct (arrow) fistulizing in the gastric submucosa (asterisk)   
